San Diego, CA, United States of America

Esther Martinborough

USPTO Granted Patents = 77 

 

 

Average Co-Inventor Count = 6.7

ph-index = 10

Forward Citations = 368(Granted Patents)

Forward Citations (Not Self Cited) = 206(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Mas-Related G-Protein Receptor X2
Mas-Related G-Protein Receptor X4
GLP-1 Receptor Modulators
Sphingosine 1 Phosphate Receptor Modulators
Ion Channel Modulators
Pyrrolidinone Benzenesulfonamide Derivatives
Bicyclic Derivatives
Selective Heterocyclic Sphingosine 1 Phosphate Receptor Modulators
Voltage-Gated Ion Channels
Quinazoles
Pyrimidines
Calcium Channel Modulators
77 patents (USPTO):Explore Patents

Title: Esther Martinborough: Pioneer in MRGPRX2 Modulation

Introduction

Esther Martinborough is a notable inventor located in San Diego, California, whose contributions to the pharmaceutical field are significant. With a remarkable portfolio of 79 patents, her work primarily focuses on modulators of the mas-related G-protein receptor X2 (MRGPRX2) and its related products and methods.

Latest Patents

Among her latest patents, Martinborough has developed methods for modulating MRGPRX2 and treating conditions dependent on this receptor. These methods highlight the administration of an effective amount of a compound that interacts with MRGPRX2, including various forms such as salts, isomers, and isotopes. Her innovations also encompass pharmaceutical compositions containing these compounds, which are crucial for advancing medical treatments involving MRGPRX2.

Career Highlights

Throughout her career, Esther has been associated with leading pharmaceutical companies such as Vertex Pharmaceuticals, Inc. and Escient Pharmaceuticals, Inc. Her experience in these organizations has played a pivotal role in her development as an inventor, enabling her to apply her scientific knowledge in practical and groundbreaking ways.

Collaborations

Martinborough's career has seen her work alongside esteemed colleagues, including Andreas Peter Termin and Liming Huang. These collaborative efforts have led to significant advancements in research and the development of innovative therapies.

Conclusion

Esther Martinborough continues to be an influential figure in the field of pharmaceutical innovations. Her substantial number of patents reflects her dedication to research and her commitment to improving medical therapies for various conditions through MRGPRX2 modulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…